INCY vs STAA · P/E 14, rev $5.14B vs rev $187.1M
Incyte Corporation (INCY) versus STAAR Surgical Company (STAA) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
STAAR Surgical Company (STAA) is a medical instruments & supplies company listed on NASDAQ.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported STAA revenue for 2026-07-03 was $187.1M. Net income was $13.3M. STAA currently screens at market cap $1.45B.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. STAA currently screens at market cap $1.45B.
Not investment advice. Open the INCY and STAA stock pages for the full models.
Not investment advice.